Functional screening assays with neurons generated from pluripotent stem cell-derived neural stem cells

Journal of Biomolecular Screening

Volumn 19, Issue 1, 2014, Pages 32-43

  Efthymiou, Anastasia ^a   Shaltouki, Atossa ^b   Steiner, Joseph P ^c   Jha, Balendu ^a   Heman Ackah, Sabrina M ^a   Swistowski, Andrzej ^d   Zeng, Xianmin ^b   Rao, Mahendra S ^a,e   Malik, Nasir ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^c National Institute of Neurological Disorders   (United States)

^d XCell Science Inc   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

drug discovery; neural stem cells; neurons

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ARTICLE; ASTROCYTE; BRAIN CELL; CELL FUNCTION; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; IMMUNOCYTOCHEMISTRY; MICROARRAY ANALYSIS; MITOCHONDRION; MOTONEURON; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME LAPSE IMAGING;

DRUG DISCOVERY; NEURAL STEM CELLS; NEURONS;

BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; COCULTURE TECHNIQUES; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, REPORTER; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; NEURAL STEM CELLS; NEURONS; PLURIPOTENT STEM CELLS;

EID: 84890842518     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057113501869     Document Type: Article

References (27)

1. Gil-Ad I., Shtaif B., Levkovitz Y., et al. Characterization of Phenothiazine-Induced Apoptosis in Neuroblastoma and Glioma Cell Lines: Clinical Relevance and Possible Application for Brain-Derived Tumors. J. Mol. Neurosci. 2004 ; 22: 189-198
2. Barber S. C., Higginbottom A., Mead R. J., et al. An In Vitro Screening Cascade to Identify Neuroprotective Antioxidants in ALS. Free Radical Biol. Med. 2009 ; 46: 1127-1138
3. Pollitt S. K., Pallos J., Shao J., et al. A Rapid Cellular FRET Assay of Polyglutamine Aggregation Identifies a Novel Inhibitor. Neuron. 2003 ; 40: 685-694
4. Pouton C. W., Haynes J. M.. Embryonic Stem Cells as a Source of Models for Drug Discovery. Nat. Rev. Drug Discovery. 2007 ; 6: 605-616
5. Raff M.. Adult Stem Cell Plasticity: Fact or Artifact?. Annu. Rev. Cell Dev. Biol. 2003 ; 19: 1-22
6. Sandrock R. W., Wheatley W., Levinthal C., et al. Isolation, Characterization and Preclinical Development of Human Glial-Restricted Progenitor Cells for Treatment of Neurological Disorders. Regen Med. 2010 ; 5: 381-394
7. Lehmann H. C., Chen W., Mi R., et al. Human Schwann Cells Retain Essential Phenotype Characteristics after Immortalization. Stem Cells Dev. 2012 ; 21: 423-431
8. Chen W., Mi R., Haughey N., et al. Immortalization and Characterization of a Nociceptive Dorsal Root Ganglion Sensory Neuronal Line. J. Peripher. Nerv. Syst. 2007 ; 12: 121-130
9. Gray J. A., Grigoryan G., Virley D., et al. Conditionally Immortalized Multipotential and Multifunctional Neural Stem Cell Lines as an Approach to Clinical Transplantation. Cell Transplant. 2000 ; 9: 153-168
10. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell. 2007 ; 131: 861-872
11. Yu J., Vodyanik M. A., Smuga-Otto K., et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells. Science. 2007 ; 318: 1917-1920
12. Carpenter M. K., Frey-Vasconcells J., Rao M. S.. Developing Safe Therapies from Human Pluripotent Stem Cells. Nat. Biotechnol. 2009 ; 27: 606-613
13. Malik N., Rao M. S.. Assessing iPSC Reprogramming Methods for their Suitability in Translational Medicine. J. Cell. Biochem. 2012 ; 113: 3061-3068
14. Grskovic M., Jahaverian A., Strulovici B., et al. Induced Pluripotent Stem Cells - Opportunities for Disease Modeling and Drug Discovery. Nat. Rev. Drug Discov. 2011 ; 10: 915-929
15. Falk A., Koch P., Kesavan J. Capture of Neuroepithelial-like Stem Cells from Pluripotent Stem Cells Provides a Versatile System for In Vitro Production of Human Neurons. PLoS One. 2012 ; 7: e29597
16. Chambers S. M., Fasano C. A., Papapetrou E. P., et al. Highly Efficient Neural Conversion of Human ES and iPS cells by Dual Inhibition of SMAD Signaling. Nat. Biotechnol. 2009 ; 27: 275-280
17. Swistowski A., Peng J., Han Y., et al. Xeno-free Defined Conditions for Culture of Human Embryonic Stem Cells, Neural Stem Cells and Dopaminergic Neurons Derived from Them. PLoS One. 2009 ; 14: e6233
18. Yan Y., Shin S., Jha B. S, et al. Efficient and Rapid Derivation of Primitive Neural Stem Cells and Generation of Brain Subtype Neurons from Human Pluripotent Stem Cells. Stem Cells Transl. Med. :
19. MacArthur C. C., Xue H., Van Hoof D., et al. Chromatin Insulator Elements Block Transgene Silencing in Engineered Human Embryonic Stem Cell Lines at a Defined Chromosome 13 Locus. Stem Cells Dev. 2012 ; 21: 191-205
20. Shaltouki A., Peng J., Liu Q., et al. Efficient Generation of Astrocytes from Human Pluripotent Stem Cells in Defined Conditions. Stem Cells. 2013 ; 31: 941-952
21. Swistowski A., Peng J., Liu Q., et al. Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells under Defined Conditions. Stem Cells. 2010 ; 28: 1893-1904
22. Peng J., Liu Q., Rao M. S., et al. Using Human Pluripotent Stem Cell-Derived Dopaminergic Neurons to Evaluate Candidate Parkinson's Disease Therapeutic Agents in MPP+ and Rotenon Models. J. Biomol. Screen. 2013 ; 18: 522-533
23. Karra D., Dahm R.. Transfection Techniques for Neuronal Cells. J. Neurosci. 2010 ; 30: 6171-6177
24. Exner N., Lutz A. K., Haass C. Mitochondrial Dysfunction in Parkinson's Disease: Molecular Mechanisms and Pathophysiological Consequences. EMBO J. 2012 ; 31: 3038-3062
25. Ames R. S., Kost T. A., Condreay J. P.. BacMam Technology and Its Application to Drug Discovery. Expert Opin. Drug Discov. 2007 ; 2: 1669-1681
26. Roussel B. D., Kruppa A. J., Miranda E., et al. Endoplasmic Reticulum Dysfunction in Neurological Disease. Lancet Neurol. 2013 ; 12: 105-118
27. Bezprozvanny I., Mattson M. P.. Neuronal Calcium Mishandling and the Pathogenesis of Alzheimer's Disease. Trends Neurosci. 2008 ; 31: 454-463